1
|
de Almeida C, Motta LC, Folli GS, Marcarini WD, Costa CA, Vilela ACS, Barauna VG, Martin FL, Singh MN, Campos LCG, Costa NL, Vassallo PF, Chaves AR, Endringer DC, Mill JG, Filgueiras PR, Romão W. MALDI(+) FT-ICR Mass Spectrometry (MS) Combined with Machine Learning toward Saliva-Based Diagnostic Screening for COVID-19. J Proteome Res 2022; 21:1868-1875. [PMID: 35880262 PMCID: PMC9344790 DOI: 10.1021/acs.jproteome.2c00148] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2022] [Indexed: 11/28/2022]
Abstract
Rapid identification of existing respiratory viruses in biological samples is of utmost importance in strategies to combat pandemics. Inputting MALDI FT-ICR MS (matrix-assisted laser desorption/ionization Fourier-transform ion cyclotron resonance mass spectrometry) data output into machine learning algorithms could hold promise in classifying positive samples for SARS-CoV-2. This study aimed to develop a fast and effective methodology to perform saliva-based screening of patients with suspected COVID-19, using the MALDI FT-ICR MS technique with a support vector machine (SVM). In the method optimization, the best sample preparation was obtained with the digestion of saliva in 10 μL of trypsin for 2 h and the MALDI analysis, which presented a satisfactory resolution for the analysis with 1 M. SVM models were created with data from the analysis of 97 samples that were designated as SARS-CoV-2 positives versus 52 negatives, confirmed by RT-PCR tests. SVM1 and SVM2 models showed the best results. The calibration group obtained 100% accuracy, and the test group 95.6% (SVM1) and 86.7% (SVM2). SVM1 selected 780 variables and has a false negative rate (FNR) of 0%, while SVM2 selected only two variables with a FNR of 3%. The proposed methodology suggests a promising tool to aid screening for COVID-19.
Collapse
Affiliation(s)
- Camila
M. de Almeida
- Chemistry
Department, Federal University of Espírito
Santo, Vitória, ES 29040-090, Brazil
| | - Larissa C. Motta
- Chemistry
Department, Federal University of Espírito
Santo, Vitória, ES 29040-090, Brazil
| | - Gabriely S. Folli
- Chemistry
Department, Federal University of Espírito
Santo, Vitória, ES 29040-090, Brazil
| | - Wena D. Marcarini
- Department
of Physiological Sciences, Federal University
of Espírito Santo, Vitória, ES 29040-090, Brazil
| | - Camila A. Costa
- School
of Dentistry, Department of Stomatology (Oral Pathology), Federal University of Goiás, Goiânia, GO 74000-000, Brazil
| | - Ana C. S. Vilela
- School
of Dentistry, Department of Stomatology (Oral Pathology), Federal University of Goiás, Goiânia, GO 74000-000, Brazil
| | - Valério G. Barauna
- Department
of Physiological Sciences, Federal University
of Espírito Santo, Vitória, ES 29040-090, Brazil
| | | | - Maneesh N. Singh
- Biocel
UK Ltd., 15 Riplingham
Road, West Ella, Hull HU10
6TS, U.K.
| | - Luciene C. G. Campos
- Department
of Biological Science, Santa Cruz State
University, Ilhéus, BA 45662-900, Brazil
| | - Nádia L. Costa
- School
of Dentistry, Department of Stomatology (Oral Pathology), Federal University of Goiás, Goiânia, GO 74000-000, Brazil
| | - Paula F. Vassallo
- Clinical
Hospital, Federal University of Minas Gerais, Belo Horizonte, MG 31270-901, Brazil
| | - Andrea R. Chaves
- Chromatography
and Mass Spectrometry Laboratory, Institute of Chemistry, Federal University of Goiás, Goiânia, GO 74690-900, Brazil
| | - Denise C. Endringer
- Pharmaceutical
Science Graduate Program, Universidade Vila
Velha, Vila Velha, ES 29106-010, Brazil
| | - José G. Mill
- Department
of Physiological Sciences, Federal University
of Espírito Santo, Vitória, ES 29040-090, Brazil
| | - Paulo R. Filgueiras
- Chemistry
Department, Federal University of Espírito
Santo, Vitória, ES 29040-090, Brazil
| | - Wanderson Romão
- Chemistry
Department, Federal University of Espírito
Santo, Vitória, ES 29040-090, Brazil
- Science
Department, Federal Institute of Education,
Science, and Technology of Espírito Santo, Vila Velha, ES 29106-010, Brazil
| |
Collapse
|
2
|
EndoProteoFASP as a Tool to Unveil the Peptidome-Protease Profile: Application to Salivary Diagnostics. Methods Mol Biol 2018; 1719:293-310. [PMID: 29476519 DOI: 10.1007/978-1-4939-7537-2_19] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Abstract
In the quest to fully comprehend the proteolytic events leading to the generation of the salivary peptidome, we have developed a method for the sequential elution of salivary peptides throughout progressive endogenous proteolysis. By screening the time-dependent changes in the salivary peptidome we can predict the activity pattern of salivary proteases responsible for such peptide fingerprint and identify susceptible protein targets. Herein, we describe a step-by-step tutorial based on a filter-aided sample preparation (FASP) method, taking advantage of the endogenous salivary proteases armamentarium (endoProteoFASP), to produce new peptides from the salivary proteins, adding to those present in the sample at the time of collection. In this protocol, the different sets of peptides retrieved after sample elution are identified following a liquid chromatography-tandem mass spectrometry approach. The likelihood of a large set of endogenous proteases (collected from several public sources) to be responsible for the generation of such peptides can be predicted by the analysis of the cleavage site specificity by Proteasix ( http://proteasix.cs.man.ac.uk /) algorithm. The attained peptidome-protease profile can be useful to elucidate the peptidome dynamics and the proteolytic events underpinning pathophysiological phenomena taking place locally within the oral cavity. This may help clinicians to diagnose oral pathologies and develop preventive therapeutic plans.
Collapse
|
3
|
Trindade F, Amado F, Gomes PS, Vitorino R. endoProteoFASP: A novel FASP approach to profile salivary peptidome and disclose salivary proteases. Talanta 2015; 132:486-93. [DOI: 10.1016/j.talanta.2014.09.026] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2014] [Revised: 09/11/2014] [Accepted: 09/13/2014] [Indexed: 12/13/2022]
|
5
|
Amado FML, Ferreira RP, Vitorino R. One decade of salivary proteomics: current approaches and outstanding challenges. Clin Biochem 2012; 46:506-17. [PMID: 23103441 DOI: 10.1016/j.clinbiochem.2012.10.024] [Citation(s) in RCA: 82] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2012] [Revised: 10/13/2012] [Accepted: 10/16/2012] [Indexed: 12/12/2022]
Abstract
Efforts have been made in the last decade towards the complete characterization of saliva proteome using gel-based and gel-free approaches. The combination of these strategies resulted in the increment of the dynamic range of saliva proteome, which yield in the identification of more than 3,000 different protein species. Comparative protein profiling using isotope labeling and label free approaches has been used for the identification of novel biomarkers for oral and related diseases. Although progresses have been made in saliva proteome characterization, the comparative profiling in different pathophysiological conditions is still at the beginning if compared to other bodily fluids. The potential biomarkers identified so far lack specificity once common differentially expressed proteins were detected in the saliva of patients with distinct diseases. In addition, recent research works focused on saliva peptidome profiling already allowed a better understanding of peptides' physiological role in oral cavity. This review provides an overview of the major achievements in saliva proteomics giving emphasis to methodological concerns related with saliva collection, treatment and analysis, as well as the main advantages and pitfalls underlying salivary proteomic strategies and potential clinical outcomes.
Collapse
Affiliation(s)
- Francisco M L Amado
- QOPNA, Mass Spectrometry Center, Department of Chemistry, University of Aveiro, Aveiro, Portugal.
| | | | | |
Collapse
|
6
|
Morzel M, Jeannin A, Lucchi G, Truntzer C, Pecqueur D, Nicklaus S, Chambon C, Ducoroy P. Human infant saliva peptidome is modified with age and diet transition. J Proteomics 2012; 75:3665-73. [PMID: 22575268 DOI: 10.1016/j.jprot.2012.04.028] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2012] [Accepted: 04/18/2012] [Indexed: 11/16/2022]
Abstract
In order to describe developmental changes in human salivary peptidome, whole saliva was obtained from 98 infants followed longitudinally at 3 and 6months of age. Data on teeth eruption and diet at the age of 6months were also recorded. Salivary peptide extracts were characterised by label-free MALDI-MS. Peptides differentially expressed between the two ages, and those significantly affected by teeth eruption or introduction of solid foods were identified by MALDI TOF-TOF and LC ESI MS-MS. Out of 81 peaks retained for statistical analysis, 26 were overexpressed at the age of 6months. Exposure to solid foods had a more pronounced effect on profiles (overexpression of nine peaks) than teeth eruption (overexpression of one peak). Differential peaks corresponded to fragments of acidic and basic PRPs, statherin and histatin. Comparison with existing knowledge on adult saliva peptidome revealed that proteolytic processing of salivary proteins is qualitatively quite comparable in infants and in adults. However, age and diet are modulators of salivary peptidome in human infants.
Collapse
Affiliation(s)
- Martine Morzel
- CNRS, UMR6265 Centre des Sciences du Goût et de l'Alimentation, F-21000 Dijon, France.
| | | | | | | | | | | | | | | |
Collapse
|